An interventional study of lifestyle modification (exercise and control of diet) in Psoriasis, Metabolic Syndrome and Erectile Dysfunction, sponsored by Cairo University. Status unknown at 1 site in Egypt. Open to male participants aged 35 Years to 45 Years. Per ClinicalTrials.gov, last updated 2022-11-30.
Sponsored by Cairo University · Not applicable, Interventional, and Treatment
complaint of sexual dysfunction and metabolic syndrome are highly reported in men with psoriasis
erectile dysfunction (ED) psoriatic men with metabolic syndrome (number of the patients will be 60) will assigned to study group (group = 30 patients) that will receive lifestyle changes (12 weeks of low calorie diet and moderate-intensity walking on treadmill, the walking duration will be 40 minutes, the walking will be three times per week) or control group (group=30 patients) that will receive no lifestyle changes/modifications.
1,928 studies on the registry are indexed under Psoriasis; 234 are open to participants now.
This study's planned enrollment of 60 is below the median of 70 across 1,472 interventional studies indexed under Psoriasis.
Browse Psoriasis studies →Cairo University is the lead sponsor of 4,907 studies on the registry; 1,445 are open to participants now.
Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
erectile dysfunction (ED) psoriatic men with metabolic syndrome (group = 30 patients) will receive lifestyle changes (12 weeks of low calorie diet and moderate-intensity walking on treadmill, the walking duration will be 40 minutes, the walking will be three times per week)
Behavioral: lifestyle modification (exercise and control of diet)
erectile dysfunction (ED) psoriatic men with metabolic syndrome (number of the patients will be 30) that will receive no lifestyle changes/modifications.
erectile dysfunction (ED) psoriatic men with metabolic syndrome that will receive lifestyle changes (12 weeks of low calorie diet and moderate-intensity walking on treadmill, the walking duration will be 40 minutes, the walking will be three times per week)
International Index of Erectile Function
Arabic version of this 5-item questionnaire will used to assess erectile function/dysfunction
Time frame: It will be measured after 12-week intervention
psoriasis area and severity index
it is a tool used to measure the severity and extent of psoriasis.
Time frame: It will be measured after 12-week intervention
body mass index
patients will be assessed with empty bowel and bladder
Time frame: It will be measured after 12-week intervention
systolic blood pressure
it will be measured using sphygmomanometer
Time frame: It will be measured after 12-week intervention
diastolic blood presure
it will be measured using sphygmomanometer
Time frame: It will be measured after 12-week intervention
waist circumference
it will be measured by in elastic tape
Time frame: It will be measured after 12-week intervention
blood glucose
it will be measured in fasting status
Time frame: It will be measured after 12-week intervention
triglycerides
it will be measured in serum
Time frame: It will be measured after 12-week intervention
high density lipoprotein
it will be measured in serum
Time frame: It will be measured after 12-week intervention
Started Oct 2022 (actual). Primary completion is estimated for Apr 2023, 6 months after the start.
Of 118 non-industry interventional studies with no phase under Psoriasis, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 41. This study's planned 6 months is below that.
Counting every sponsor, half of 136 studies reached it within 18 months; a quarter within 8 and three quarters within 37.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Nov 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.